Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer

Withdrawn

• Conditions: Gastrointestinal Hemorrhage; Ulcer

• Registration Number: NCT01215058
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to assess gastroprotective agent compliance in patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer with NSAID.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-09-28
• Status Verified: 2010-10
• Study Start: 2010-10
• Study First Submitted QC: 2010-10-04
• Study First Posted: 2010-10-05
• Last Update Submitted: 2010-10-21
• Last Update Posted: 2010-10-22
• Primary Completion: 2011-04
• Study Completion: 2011-04

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer confirmed by endoscopy

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gastroprotective agent compliance	At the end of 1 month

Secondary Outcome Measures

Name	Time	Method
Clinical characteristics of those ulcers with NSAID	At the end of 1 month